Trial Profile
A Phase 1, Open-label Study to Compare the Pharmacokinetics and Pharmacodynamics of Warfarin and Esmolol in the Absence and Presence of MEDI0382 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jul 2019
Price :
$35
*
At a glance
- Drugs Cotadutide (Primary) ; Esmolol; Warfarin
- Indications Non-alcoholic steatohepatitis; Obesity; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors MedImmune
- 11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
- 24 Apr 2018 Status changed from active, no longer recruiting to completed.
- 28 Mar 2018 Planned End Date changed from 10 May 2018 to 9 Apr 2018.